Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q2

4885.TEDINET S100PYKH
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-06-01 → 2021-11-30StandaloneNet sales
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Operating income¥323m2021-06-01 → 2021-11-30StandaloneOperating income
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥324m2021-06-01 → 2021-11-30StandaloneOrdinary income
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Profit before tax¥324m2021-06-01 → 2021-11-30StandaloneIncome before income taxes
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥262m2021-06-01 → 2021-11-30StandaloneProfit loss
Total assets¥5.0bnat 2022-11-30StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.5bnat 2021-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2022-11-30StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2021-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥765mat 2022-11-30StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31StandaloneCash and cash equivalents
Cash & equivalents¥839mat 2021-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥525m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥152m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥176m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥56m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥484m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥257m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥71.352021-06-01 → 2021-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥37.972021-09-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.362021-06-01 → 2021-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio34.6%at 2021-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥40m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥278m
—segment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
—segment totalsegment profit2021-06-01 → 2021-11-30¥323m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥323m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember2807947000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember2807947000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember2807947000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember278240000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember40247000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember4767000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember323255000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember323255000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember323255000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember1778940000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember377285000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember965019000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3121245000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3121245000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember3121245000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember1778940000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember377285000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember965019000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3121245000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3121245000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember3121245000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember283961000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember-38723000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember-19828000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember225409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember225409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember225409000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2023-01-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第77期第2四半期(自 2022年9月1日　至 2022年11月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)室町ケミカル株式会社
Company name in english cover pageFilingDateInstantMUROMACHI CHEMICALS INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　青木　淳一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number address of registered headquarter cover pageFilingDateInstant0944-41-2131
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理本部長　　井内　聡

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2022-11-30pass